Stay updated on Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page
- ChecktodayChange DetectedWave Life Sciences USA, Inc. is now listed as the sponsor, replacing Wave Life Sciences Ltd. The document revision on the page was updated from v3.5.4 to v3.5.5, indicating a newer version of the study data.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision tag v3.5.4 was added to the study record, replacing the previous v3.5.3 in the revision history, indicating an update to the entry's documentation.SummaryDifference0.1%

- Check36 days agoChange Detected- Revision label updated from v3.5.2 to v3.5.3, signaling a minor update to the page’s backend or content. No study-specific details or results are altered by this change.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0. No changes to study details or user-facing content.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

Stay in the know with updates to Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.